Stanley G. Nathenson

Stanley G. Nathenson's AcademicInfluence.com Rankings

Biology

#9966

World Rank

#13239

Historical Rank

Immunology

#613

World Rank

#633

Historical Rank

Molecular Biology

#1400

World Rank

#1427

Historical Rank

Biochemistry

#1548

World Rank

#1678

Historical Rank

biology Degrees

Download Badge

Biology

Stanley G. Nathenson's Degrees

PhD Biochemistry University of California, San Francisco
Bachelors Chemistry Stanford University

Why Is Stanley G. Nathenson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Stanley G. Nathenson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule (1990) (668)
Identification of the β cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes (2003) (390)
Structural and functional analysis of the costimulatory receptor programmed death-1. (2004) (349)
Structural basis for co-stimulation by the human CTLA-4/B7-2 complex (2001) (342)
Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex (2001) (339)
Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition. (1992) (305)
Programmed death-1 (PD-1)–deficient mice are extraordinarily sensitive to tuberculosis (2010) (276)
Murine major histocompatibility complex class-I mutants: molecular analysis and structure-function implications. (1986) (273)
The three-dimensional structure of H-2Db at 2.4 Å resolution: Implications for antigen-determinant selection (1994) (268)
Three cDNA clones encoding mouse transplantation antigens: Homology to immunoglobulin genes (1981) (229)
Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement. (1998) (211)
T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface. (2007) (196)
Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2 (2008) (184)
Atomic structure of an αβ T cell receptor (TCR) heterodimer in complex with an anti‐TCR Fab fragment derived from a mitogenic antibody (1998) (176)
Mitotic recombination in germ cells generated two major histocompatibility complex mutant genes shown to be identical by RNA sequence analysis: Kbm9 and Kbm6. (1986) (175)
Mature T cell reactivity altered by peptide agonist that induces positive selection (1996) (174)
Identification of a CD8 T Cell That Can Independently Mediate Autoimmune Diabetes Development in the Complete Absence of CD4 T Cell Helper Functions1 (2000) (172)
Biochemistry of the gene products from murine MHC mutants. (1980) (171)
Primary structural: analysis of the transplantation antigens of the murine H-2 major histocompatibility complex. (1981) (165)
T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. (2005) (159)
Spontaneous H-2 mutants provide evidence that a copy mechanism analogous to gene conversion generates polymorphism in the major histocompatibility complex. (1983) (157)
Primary structure of a murine transplantation antigen (1981) (156)
A general method for facilitating heterodimeric pairing between two proteins: application to expression of alpha and beta T-cell receptor extracellular segments. (1994) (153)
Evidence that multiple residues on both the α-helices of the class I MHC molecule are simultaneously recognized by the T cell receptor (1988) (145)
Structure of murine CTLA-4 and its role in modulating T cell responsiveness. (2000) (141)
Identification of a common docking topology with substantial variation among different TCR–peptide–MHC complexes (1998) (130)
B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties. (2006) (126)
Structural mechanisms of costimulation (2002) (126)
Biochemical properties and immunochemical-genetic relationships of mouse H-2 alloantigens. (1974) (124)
Isolation of H-2 alloantigens solubilized by the detergent NP-40. (1971) (122)
Activated TCRs remain marked for internalization after dissociation from pMHC (2002) (122)
Murine histocompatibility-2 (H-2) alloantigens. Purification and some chemical properties of soluble products from H-2b and H-2d genotypes released by papain digestion of membrane fractions. (1969) (115)
Membrane molecules determined by the H-2 associated immune response region: isolation and some properties. (1974) (113)
Chemical structure of teichoic acid from Staphylococcus aureus, strain Copenhagen. (1962) (109)
Notable diversity in peptide composition of murine H-2K and H-2D alloantigens. (1974) (106)
Structural and Serological Properties of Murine Ia Alloantigens (1976) (106)
Evidence that the antigen receptors of cytotoxic T lymphocytes interact with a common recognition pattern on the H-2Kb molecule. (1995) (103)
Crystal structure of the receptor-binding domain of human B7-2: Insights into organization and signaling (2003) (103)
Different cell surface oligomeric states of B7-1 and B7-2: Implications for signaling (2005) (103)
A nonpolymorphic major histocompatibility complex class Ib molecule binds a large array of diverse self-peptides (1994) (103)
Comparison of the cloned H-2Kbm1 variant gene with the H-2Kb gene shows a cluster of seven nucleotide differences. (1983) (102)
The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum (2008) (102)
The structure of the antigen-binding groove of major histocompatibility complex class I molecules determines specific selection of self-peptides. (1991) (101)
The three-dimensional structure of an H-2Ld-peptide complex explains the unique interaction of Ld with beta-2 microglobulin and peptide. (1997) (98)
Vesicular stomatitis virus antigenic octapeptide N52-59 is anchored into the groove of the H-2Kb molecule by the side chains of three amino acids and the main-chain atoms of the amino terminus. (1992) (97)
H-2 histocompatibility alloantigens. Some biochemical properties of the molecules solubilized by NP-40 detergent. (1973) (91)
Sequence, structure, function, immunity: structural genomics of costimulation (2009) (90)
Structure and T cell inhibition properties of B7 family member, B7-H3. (2013) (81)
NTB-A receptor crystal structure: insights into homophilic interactions in the signaling lymphocytic activation molecule receptor family. (2006) (72)
Evolution of GITRL immune function: Murine GITRL exhibits unique structural and biochemical properties within the TNF superfamily (2008) (72)
Human lymphocyte membrane (HL-A) alloantigens: isolation, purification and properties. (1969) (70)
Assembly and structural properties of glucocorticoid-induced TNF receptor ligand: Implications for function (2007) (69)
Structure of CD84 provides insight into SLAM family function (2007) (66)
Cell-surface glycopeptides: growth-dependent changes in the carbohydrate-peptide linkage region. (1973) (64)
Regeneration of transplantation antigens on mouse cells. (1971) (62)
Antigenic variants of measles virus (1981) (59)
Intramolecular organization of Class I H-2 MHC antigens; localization of the alloantigenic determinants and the beta 2 m binding site to different regions of the H-2 Kb glycoprotein. (1983) (58)
The genome-linked protein of picornaviruses. VII. Genetic mapping of poliovirus VPg by protein and RNA sequence studies (1980) (56)
Characterization of an incompletely assembled major histocompatibility class I molecule (H-2Kb) associated with unusually long peptides: implications for antigen processing and presentation. (1994) (55)
On defining the rules for interactions between the T cell receptor and its ligand: a critical role for a specific amino acid residue of the T cell receptor beta chain. (1998) (55)
Biochemical properties of histocompatibility antigens. (1970) (54)
Localization of the papain cleavage site of H-2 glycoproteins. (1976) (54)
Molecular Recognition of Human CD1b Antigen Complexes: Evidence for a Common Pattern of Interaction with αβ TCRs1 (2000) (54)
Suppression of immunoglobulin synthesis by cellular hybridization. (1971) (54)
During the early prediabetic period in NOD mice, the pathogenic CD8(+) T-cell population comprises multiple antigenic specificities. (2002) (52)
Studies on the carbohydrate portion of membrane-located mouse H-2 alloantigens. (1970) (51)
Methods to study peptides associated with MHC class I molecules. (1994) (50)
Decoy strategies: the structure of TL1A:DcR3 complex. (2011) (50)
Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis. (1997) (48)
Solubilization and partial purification of mouse histocompatibility antigens from a membranous lipoprotein fraction. (1966) (48)
Primary structural studies of an H-2L molecule confirm that it is a unique gene product with homology to H-2K and H-2D antigens. (1980) (47)
Tissue-expressed B7-H1 critically controls intestinal inflammation. (2014) (47)
The molecular basis of codominant expression of the histocompatibility-2 genetic region. (1972) (47)
Solubilization of Human Leucocyte Membrane Isoantigens (1968) (46)
How H13 Histocompatibility Peptides Differing by a Single Methyl Group and Lacking Conventional MHC Binding Anchor Motifs Determine Self-Nonself Discrimination1 (2002) (46)
Autoreactive diabetogenic T-cells in NOD mice can efficiently expand from a greatly reduced precursor pool. (2001) (46)
Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence studies of the cyanogen bromide fragments of the H-2Kb glycoprotein. (1978) (45)
Diversity of T cell receptors specific for the VSV antigenic peptide (N52-59) bound by the H-2Kb class I molecule. (1995) (45)
Interaction between Kb and Q4 gene sequences generates the Kbm6 mutation (1986) (44)
Three spontaneous H-2Db mutants are generated by genetic micro- recombination (gene conversion) events. Impact on the H-2-restricted immune responsiveness (1988) (44)
Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein. (1980) (44)
Structure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy (2017) (43)
Structure of Nectin-2 reveals determinants of homophilic and heterophilic interactions that control cell–cell adhesion (2012) (43)
Recombination and the concerted evolution of the murine MHC (1987) (42)
Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria. (1999) (42)
SOME BIOCHEMICAL PROPERTIES OF THYMUS LEUKEMIA ANTIGENS SOLUBILIZED FROM CELL MEMBRANES BY PAPAIN DIGESTION (1973) (40)
The distribution of alloantigenic specificities of native H-2 products. (1972) (39)
Structural features of MHC class I molecules that might facilitate alternative pathways of presentation. (2000) (39)
Conservation and diversity in the class I genes of the major histocompatibility complex: sequence analysis of a Tlab gene and comparison with a Tlac gene. (1986) (39)
Altered Peptide Ligand-Mediated TCR Antagonism Can Be Modulated by a Change in a Single Amino Acid Residue Within the CDR3β of an MHC Class I-Restricted TCR1 (2000) (38)
Expression, refolding, purification, molecular characterization, crystallization, and preliminary X-ray analysis of the receptor binding domain of human B7-2. (2002) (36)
Intracellular transport of class I histocompatibility molecules. Influence of protein folding on transport to the cell surface. (1988) (36)
The firstH- 2 mutant workshop (1978) (36)
ENZYMATIC SYNTHESIS OF THE PEPTIDE IN BACTERIAL URIDINE NUCLEOTIDES. IV. PURIFICATION AND PROPERTIES OF D-GLUTAMIC ACID-ADDING ENZYME. (1964) (36)
Enzymatic synthesis and immunochemistry of alpha- and beta-N-acetylglucosaminylribitol linkages in teichoic acids from several strains of Staphylococcus aureus. (1966) (36)
Three distinct signals can induce class II gene expression in a murine pre-B-cell line. (1986) (34)
Synthetic peptide libraries in the determination of T cell epitopes and peptide binding specificity of class I molecules (1992) (33)
Solubilization of membrane H-2 isoantigens: chromatographic separation of specificities determined by a single H-2 genotype. (1967) (33)
Identification of the Cloned Gene for the Murine Transplantation Antigen H-2Kb by Hybridization with Synthetic Oligonucleotides (1983) (33)
Isolation of a chromatographically unique glycopeptide from murine histocompatibility-2 (H-2) membrane alloantigens labelled with H3-fucose of H3-glucosamine. (1970) (32)
A simplified procedure for the preparation of MHC/peptide tetramers: chemical biotinylation of an unpaired cysteine engineered at the C-terminus of MHC-I. (2000) (31)
Erratum: Structural and functional analysis of the costimulatory receptor programmed death-1 (Immunity (March 2004) 20 (337-347)) (2004) (31)
Crystallization of a Deglycosylated T Cell Receptor (TCR) Complexed with an Anti-TCR Fab Fragment* (1996) (31)
Alloreactivity, Antigen Recognition and T‐Cell Selection: Three Diverse T‐Cell Recognition Problems with a Common Solution (1996) (31)
Structural Basis of Inducible Costimulator Ligand Costimulatory Function: Determination of the Cell Surface Oligomeric State and Functional Mapping of the Receptor Binding Site of the Protein1 (2006) (31)
Single amino acid replacements in an antigenic peptide are sufficient to alter the TCR V beta repertoire of the responding CD8+ cytotoxic lymphocyte population. (1999) (31)
Primary structure of murine major histocompatibility complex alloantigens: isolation, biochemical characterization, and preliminary alignment of CNBr fragments from the H-2Ib glycoprotein. (1978) (30)
The half‐life of the T‐cell receptor/peptide–major histocompatibility complex interaction can modulate T‐cell activation in response to bacterial challenge (2007) (29)
Further structural analysis of the murine H-2Kb glycoprotein using radiochemical methodology. (1979) (29)
Enzymatic synthesis and immunochemistry of N-acetylglucosaminylribitol linkages in the teichoic acids of Staphylococcus aureus stains. (1962) (29)
Fine specificity and MHC restriction of trinitrophenyl-specific CTL. (1999) (28)
Alterations in TCR-MHC contacts subsequent to cross-recognition of class I MHC and singly substituted peptide variants. (1998) (28)
Point mutations in the beta chain CDR3 can alter the T cell receptor recognition pattern on an MHC class I/peptide complex over a broad interface area. (1998) (28)
The role of self peptides in the allogeneic cross-reactivity of CTLs. (1995) (28)
An approach to the study of structure-function relationships of MHC class I molecules: isolation and serologic characterization of H-2Kb somatic cell variants. (1986) (28)
Cell Surface Antigen Induced by Friend Murine Leukemia Virus Is also in the Virion (1974) (27)
Analysis of somatic cell H-2 variants to define the structural requirements for class I antigen expression. (1986) (27)
Murine histocompatibility-2 (H-2) alloantigens. Purification and some chemical properties of a second class of fragments (class II) solubilized by papain from cell membranes of H-2b and H-2d mice. (1970) (27)
Biochemical and structural characterization of the human TL1A ectodomain. (2009) (26)
Direct demonstration that cytotoxic T lymphocytes recognize conformational determinants and not primary amino acid sequences (1983) (26)
Dynamic Equilibrium of B7-1 Dimers and Monomers Differentially Affects Immunological Synapse Formation and T Cell Activation in Response to TCR/CD28 Stimulation (2010) (26)
ENZYMATIC SYNTHESIS OF N-ACETYLGLUCOSAMINYLRIBITOL LINKAGES IN TEICHOIC ACID FROM STAPHYLOCOCCUS AUREUS, STRAIN COPENHAGEN. (1963) (26)
Similarity of the carbohydrate structures of H-2 and Ia glycoproteins. (1977) (26)
Effects of penicillin on the biosynthesis of the cell walls of Escherichia coli and Staphylococcus aureus. (1961) (25)
Microrecombinations generate sequence diversity in the murine major histocompatibility complex: analysis of the Kbm3, Kbm4, Kbm10, and Kbm11 mutants (1988) (24)
Structural comparisons of TL antigens derived from normal and leukemia cells of Tl+ and TL- strains and relationship to genetically linked H-2 major histocompatibility complex products. (1981) (24)
TRANSPLANTATION ANTIGENS: STUDIES OF THE MOUSE MODEL SYSTEM, SOLUBILIZATION AND PARTIAL PURIFICATION OF H‐2 ISOANTIGENS (1966) (23)
Primary structure of murine major histocompatibility complex alloantigens: completion of the sequence of the amino-terminal 284 residues of H-2Kb. (1980) (23)
Selective loss of H-2 antigenic reactivity after chemical modification. (1973) (23)
Biochemical purification of detergent-solubilized H-2 alloantigens. (1979) (22)
Comparison of alloantisera and hybridoma antibody for purification of the H-2Db murine histocompatibility antigen and preliminary molecular characterization of this antigen. (1980) (22)
THE EFFECT OF CD28/B7 BLOCKADE ON ALLOREACTIVE T AND B CELLS AFTER LIVER CELL TRANSPLANTATION 1 (2001) (22)
Functional classification of immune regulatory proteins. (2013) (21)
The interchain disulfide linkage is not a prerequisite but enhances CD28 costimulatory function. (2006) (21)
Structural studies of the protein portion of the H-2-linked Ia glycoprotein antigens of the mouse: tryptic peptide comparison of products from the I-A and I-C subregions of B10-HTT. (1978) (21)
Structural differences between parent and variant H-2K glycoproteins from mouse strains carrying H-2 gene mutations. (1977) (20)
Biochemical similarity of papain-solubilized H-2d alloantigens from tumor cells and from normal cells. (1970) (20)
Differential binding of a minor histocompatibility antigen peptide to H-2 class I molecules correlates with immune responsiveness. (1993) (19)
A Structural Difference Limited to One Residue of the Antigenic Peptide Can Profoundly Alter the Biological Outcome of the TCR-Peptide/MHC Class I Interaction1 (2001) (19)
Distribution of H-2 alloantigenic specificities on radiolabeled papain-solubilized antigen fragments. (1971) (19)
Molecular recognition of human CD1b antigen complexes: evidence for a common pattern of interaction with alpha beta TCRs. (2000) (19)
Primary structure of murine major histocompatibility alloantigens: amino acid sequence of the cyanogen bromide fragment Ia (positions 139-228) from the H-2Kb molecule. (1980) (18)
Presentation of antigenic peptides by MHC class I molecules. (1992) (18)
Regulatory variants for the expression of H-2 antigens. I. Isolation and characterization. (1976) (18)
IMMUNOGENIC PROPERTIES OF PAPAINSOLUBILIZED H-2 ALLOANTIGENS (1970) (17)
Structural and functional characterization of a single-chain peptide–MHC molecule that modulates both naive and activated CD8+ T cells (2011) (17)
Somatic cell variants express altered H-2Kb allodeterminants recognized by cytolytic T cell clones. (1986) (17)
Structural studies on H-2Db and H-2Kd molecules indicate that murine major histocompatibility b and d haplotype alloantigens share structural features. (1980) (16)
Structural studies of the H-2D products of the mouse mutant BALB/c-H-2Ddb and the parental strain BALB/cKh-H-2Dd. (1978) (16)
Amino acid sequence of cyanogen bromide fragment CN-C (residues 24-98) of the mouse histocompatibility antigen H-2Dd. A comparison of the amino-terminal 100 residues of H-2Dd, Dd, Kd, and Kb reveals discrete areas of diversity. (1981) (16)
Comparison of the peptide composition of two histocompatibility-2 alloantigens. (1970) (16)
Amino acid sequence of the carboxyl-terminal hydrophilic region of the H-2Kb MHC alloantigen. Completion of the entire primary structure of the H-2Kb molecule. (1981) (15)
Amino acid sequence of residues 1-98 of the K-2Kb murine major histocompatibility alloantigen: comparison with H-2Kb and H-2db reveals extensive localized differences. (1981) (15)
[58] Formation of UDP-acetylmuramyl peptides (1966) (15)
Evidence that protein determines ia antigenic specificity. (1975) (14)
An in vitro study of the dynamic features of the major histocompatibility complex class I complex relevant to its role as a versatile peptide-receptive molecule. (1997) (14)
Presentation by a major histocompatibility complex class I molecule of nucleoprotein peptide expressed in two different genes of an influenza virus transfectant (1995) (14)
Removal of neuraminic acid from H-2 alloantigens without effect of antigenic reactivity. (1971) (13)
Primary structure of murine major histocompatibility complex alloantigens. Amino acid sequence of the NH2-terminal ninety-eight residues of the H-2Db glycoprotein. (1981) (13)
Biochemical studies on the H-2K antigens of the MHC mutantsbm3 andbm11 (2005) (12)
Immunogenic properties of papain-solubilized alloantigen. (1971) (12)
Biochemical properties of papain-solubilized murine and human histocompatibility alloantigens. (1970) (12)
1.8 A structure of murine GITR ligand dimer expressed in Drosophila melanogaster S2 cells. (2008) (11)
Characterization of the thymus leukemia (TL) product encoded by the BALB/c T3c gene by DNA-mediated gene transfer. Comparison to the T13c product and BALB/c leukemia TL. (1989) (11)
Partition Chromatography of Yeast and Escherichia coli Soluble Ribonucleic Acid. Relation of Coding Properties to Fractionation (1965) (11)
Abnormalities in the glycosylation of immunoglobulin heavy chain and an H-2 transplantation antigen in a mouse myeloma mutant (1977) (11)
Mapping the orientation of an antigenic peptide bound in the antigen binding groove of H-2Kb using a monoclonal antibody. (1992) (11)
Structural differences between parent and mutant H-2K glycoproteins from two H-2K gene mutants: b6.c-h-2ba (Hzl) and B6-H-2bd (M505). (1977) (10)
Secondary structure of the murine histocompatibility alloantigen H-2Kb: relationship between heavy chain, beta 2-microglobulin, and antigenic reactivity. (1985) (10)
Major histocompatibility complex recognition by immune receptors: Differences among T cell receptor versus antibody interactions with the VSV8/H‐2Kb complex (1997) (10)
Regulatory variants for the expression of H-2 antigens. II. Level of discrimination of cell-mediated cytolysis. (1976) (9)
Molecular loss variants of the murine major histocompatibility complex: nonexpression of H-2K antigens associated with marked reduction in H-2K mRNA as determined by oligonucleotide hybridization analysis. (1986) (9)
Peptide comparison of two histocompatibility-2 (H-2b and H-2d) alloantigens. (1972) (9)
Biosynthetic properties of H-2 alloantigens: turnover rate in H-2 d tumor cells. (1973) (9)
In vivo CTL immunity can be elicited by in vitro reconstituted MHC/peptide complex. (1996) (9)
Studies on the FMR antigen. (1969) (9)
Increased Heterologous Protein Expression in Drosophila S2 Cells for Massive Production of Immune Ligands/Receptors and Structural Analysis of Human HVEM (2015) (8)
Biochemical studies on the H-2K antigens of the MHC mutantbm1 (2005) (8)
Comparison of the carbohydrate portion of membrane H-2 alloantigens isolated from spleen cells and tumor cells. (1971) (8)
Microrecombinations Generate Sequence Diversity in the Murine Major Histocompatibility Complex: Analysis of the K , Kb Kbm and KbmJJ Mutants (8)
FURTHER CHARACTERIZATION OF Ia (IMMUNE RESPONSE REGION ASSOCIATED) ANTIGEN MOLECULES (1974) (8)
Hapten Addition to an MHC Class I-Binding Peptide Causes Substantial Adjustments of the TCR Structure of the Responding CD8+ T Cells1 (2001) (8)
Isolation, characterization and amino acid sequence studies of the cyanogen bromide fragments of the H-2Dd glycoprotein. (1980) (8)
Biochemical studies of H-2K antigens from a group of related mutants. I. Identification of a shared mutation in B6-H-2bm5 and B6-H-2bm16 (2004) (7)
Analysis of the H-2Kbm8 mutant: correlation of structure with function. (1991) (7)
Structure of murine major histocompatibility complex alloantigens: identification of cysteine residues involved in two intrachain disulfide bonds of H-2K. (1981) (7)
Structure of H-2 Major Histocompatibility Complex Products (1981) (7)
Cytotoxic T lymphocyte recognition of novel allodeterminants expressed on in vitro selected H-2Kb mutants. (1988) (6)
Peptide presentation by major histocompatibility class I molecules. (1993) (6)
Biochemical studies of H-2K antigens from a group of related mutants. II. Identification of a shared mutation in B6-H-2bm6, B6.C-H-2bm7, and B6.C-H-2bm9 (2004) (6)
Isolation and sequence analysis of the intramembranous hydrophobic segment of the H-2Kb murine histocompatibility antigen. (1981) (6)
Comparison of soluble human and mouse transplantation antigens. (1969) (6)
Diversity of T cell receptors specific for the VSV antigenic peptide (N52-59) bound by the H-2Kb class I molecule. (1995) (5)
Cis- and trans-repression of class I major histocompatibility gene expression in Abelson virus-transformed murine leukemia. (1991) (5)
Ir associated antigens (1975) (4)
ANTIGENIC STRUCTURE OF THE Ia GLYCOPROTEIN MOLECULES (1978) (4)
The structure of TL1A-DCR3 COMPLEX (2011) (4)
Effects of Penicillin on Bacterial Cell Wall Synthesis in E. coli and in S. aureus (1958) (4)
STUDIES ON THE CHEMICAL BASIS OF VARIABILITY AND THE COMPLEX CELLULAR EXPRESSION OF THE H-2K and H-2D PRODUCTS (1976) (4)
Crystallization and preliminary X-ray analysis of the complex between human CTLA-4 and B7-2. (2001) (4)
Diversity and polymorphism in the MHC appear to be generated by a copy mechanism. (1983) (4)
Structural evidence that the small subunit found associated with the TL antigen is β2-microglobulin (2004) (4)
MHC class I-peptide interactions and TCR recognition. (1995) (3)
Nucleotide sequence of the BALB/c H-2T region gene, T3d (2004) (3)
A single amino acid substitution in the H-2Kb molecule generates a defined allogeneic epitope. (1993) (3)
A tribute to Dr. George Snell. (1997) (3)
The Analysis of H-2 Mutants: Molecular Genetics and Structure/Function Relationships (1987) (3)
Rapid in vitro assembly of class I major histocompatibility complex (1995) (3)
Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect. (2010) (3)
Crystal structure of FASL and DcR3 complex (2013) (3)
Carbohydrate structure of mouse h-2 alloantigens. Abstr. (1971) (3)
Structural analysis of H2-Db class I molecules containing two different allelic forms of the type 1 diabetes susceptibility factor beta-2 microglobulin: implications for the mechanism underlying variations in antigen presentation. (2006) (2)
Polymorphism and diversity in the Tla gene system (2004) (2)
the receptor-binding domain of human B7-2 (2003) (2)
Use of mutants to analyze regions on the H-2Kb molecule for interaction with immune receptors. (1989) (2)
Unexpected complexity of the dm1 mutation revealed in the structure of three H-2D/L-related antigens (1982) (2)
BIOCHEMICAL PROPERTIES AND IMMUNOCHEMICAL-GENETIC RELATIONSHIPS OF ALLOANTIGENS OF THE MOUSE H-2 MAJOR HISTOCOMPATIBILITY COMPLEX (1974) (2)
Solubilization, properties and molecular separation of HL-A alloantigens. (1969) (2)
Analysis of associative recognition determinants on class I H-2Kbmutant molecules (2004) (2)
Somatic cell variants of H-2k:b: A point mutation in the first extracellular domain results in altered immune recognition (2004) (2)
Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1. (1992) (2)
Crystal Structure of LIGHT (2011) (2)
IMMUNOCHEMICAL PROPERTIES AND GENETIC RELATIONSHIPS OF H-2 HISTOCOMPATIBILITY ALLOANTIGENS (1972) (2)
The structural-genetic relationships of the H-2K and H-2D products of the mouse major histocompatibility complex. (1978) (1)
The use of crystal structure analysis of recombinant class I MHC-peptide complexes to analyze the molecular basis of peptide MHC/TCR interactions (1993) (1)
Receptor Binding Site of the Protein State and Functional Mapping of the Determination of the Cell Surface Oligomeric Ligand Costimulatory Function: Structural Basis of Inducible Costimulator (2006) (1)
Somatic cell variants of the murine major histocompatibility complex (1987) (1)
Diversification of H-2 Genes through Recombination: A Study of Kb Mutants (1986) (1)
Comparison of glycopeptides from membrane located histocompatibility- -2 (h-2) alloantigens from different types of tumor cells. Abstr. (1970) (1)
MHC and Singly Substituted Peptide Variants Subsequent to Cross-Recognition of Class I Alterations in TCR-MHC Contacts (1998) (1)
Crystal structures of FasL:DcR3 and LIGHT:DcR3 complexes reveal the molecular basis for the broad specificity of DcR3 (CCR5P.255) (2014) (1)
Regulation of class II gene expression in a murine pre-B cell line. (1986) (1)
Properties of murine h-2 alloantigens solubilized from cell membranes by papain. Abstr. (1969) (1)
Biochemical analysis of related, independently arising histocompatibility mutants: bm17 and KB-98 enlarge the “bg series” of H-2Kb mutants (1990) (1)
Primary structure of murine major histocompatibility complex alloantigens : Isolation , biochemical characterization , and preliminary alignment of CNBr fragments from the H-2 Kb glycoprotein ( histocompatibility antigens / radiolabeling / immunoprecipitation ) (1)
Primary structure of murine H-2Kb and beta 2-microglobulin. (1981) (1)
Molecular distribution of h-2 alloantigenic specificities on fragments solubilized by papain from cell membranes. Abstr. (1969) (1)
CHAPTER 13 – THE ALLOGENEIC RESPONSE (1976) (1)
Biochemical aspects of histocompatibility antigens. (1971) (1)
Crystal structure of the extracellular domain of human PD-1 (2012) (1)
Crystal structure of a human light loop mutant in complex with dcr3 (2013) (1)
Inhibition through PD-1 is crucial for protection against M. tuberculosis infection (58.1) (2011) (1)
Primary Structural Analyses of Murine Major Histocompatibility Antigens (1982) (1)
Use of hybridoma-resistant variant cell lines to study H-2Db/FMR-specific cytotoxic T cells (2004) (1)
Mutants of the Murine Major Histocompatibility Complex: Structural Analysis of in Vivo and in Vitro H-2Kb Variants (1985) (1)
Biochemical analysis of related, independently arising histocompatibility mutants: bm17 and KB-98 enlarge the “bg series” of H-2Kb mutants (1990) (0)
Crystal structure of CD84: Insite into SLAM family function (2007) (0)
WORKSHOP SUMMARY: CHEMISTRY OF MHC PRODUCTS (1979) (0)
Expression and Function in a Transgenic Mouse of an H-2Kb Variant Gene Obtained by Site-Directed Mutagenesis in a Kbm1 Mutant Mouse (1990) (0)
Characteristics of Foreign and Self Peptides Endogenously Bound to MHC Class I Molecules (1992) (0)
CDR3 in a Single Amino Acid Residue Within the Antagonism Can Be Modulated by a Change Altered Peptide Ligand-Mediated TCR (2000) (0)
THE CRYSTAL STRUCTURE OF MURINE CTLA4 (CD152) (2000) (0)
Crystal structure of the second Ig-C2 domain of human Fc-receptor like A (FCRLA), Isoform 9 [NYSGRC-005836] (2012) (0)
Structure of T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT) in hexagonal crystal form (2011) (0)
Crystal Structure of mouse GITRL at 2.5 A. (2008) (0)
Crystal structure of Human LAIR-1 in C2 space group (2011) (0)
Crystal Structure of HVEM (2012) (0)
Differences in the Recognition of MHC Class I Molecules by T-Cells and Antibodies (2019) (0)
Crystal structure of GITRL from Bushbaby (2012) (0)
Relative immunogenicities of antigens of the h-2 complex. (1975) (0)
Crystal structure of light mutant2 and dcr3 complex (2013) (0)
Identification oftheCloned GenefortheMurine Transplantation Antigen H-2KbbyHybridization with Synthetic Oligonucleotides (1983) (0)
Use of hybridoma-resident variant cell lines to study H-2Db/FMR-specific cytotoxic T cells. (1981) (0)
Discrimination Motifs Determine Self-Nonself Lacking Conventional MHC Binding Anchor Differing by a Single Methyl Group and How H13 Histocompatibility Peptides (2001) (0)
Crystal structure of the receptor binding domain of mouse PD-L2 (2008) (0)
Conservation and diversity in the class I genes of the major histocompatibility complex : Sequence analysis of a Tiab gene and comparison with a Tlac gene ( multigene family / thymus leukemia antigen / DNA sequence ) (2003) (0)
Structural and functional studies on PD-1: from crystals to mice (63.17) (2011) (0)
Crystal structure of DCR3 (2011) (0)
Toward an Understanding of the Biochemical Nature of H-2 Molecules: A Historical Perspective (1987) (0)
SOME BIOCHEMICAL P ROPERTIES OF THYMUS LEUKEMIA ANTIGENS SOLUBILIZED FROM CELL MEMBRANES BY (1973) (0)
The dynamic equilibrium between dimeric and monomeric cell surface B7-1 regulates T cell activation and CD28 expression (88.1) (2007) (0)
THE THREE-DIMENSIONAL STRUCTURE OF AN H-2LD PEPTIDE COMPLEX EXPLAINS THE UNIQUE INTERACTION OF LD WITH BETA2M AND PEPTIDE (1998) (0)
Crystal structure of Rabbit GITRL (2012) (0)
Crystal structure of the mouse PD-1 Mutant and PD-L2 complex (2009) (0)
CRYSTAL STRUCTURE OF LIGHT AND DcR3 COMPLEX (2013) (0)
The role of Programmed Death-1 (PD-1) in pulmonary M. tuberculosis infection: friend or foe? (40.10) (2010) (0)
Crystal structure of SLAM family members: implications for their costimulatory functions in T cell (88.9) (2007) (0)
Crystal Structure of DcR3-TL1A complex (2010) (0)
MembraneMolecules Determined bytheH-2Associated Immune Response Region: Isolation andSomeProperties (1974) (0)
Pattern of Interaction with Antigen Complexes: Evidence for a Common Molecular Recognition of Human CD1b (2013) (0)
CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MURINE PD-1 (2004) (0)
Structure of Minor Histocompatibility Antigen peptide, H13a, complexed to H2-Db (2002) (0)
[Presence of amino sugars in the polysaccharides of the walls of hydatid cysts]. (1966) (0)
Structure of T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT) (2011) (0)
Crystal structure of murine B7-H3 extracellular domain (2012) (0)
Crystal Structure of human GITRL (2007) (0)
Crystal Structure of NTB-A (2006) (0)
23 – Localization of Immune Receptor Recognition Sites on Major Histocompatibility Molecules through the Analysis of H-2Kb Mutants (1988) (0)
The PD-1/PD-L costimulatory pathway plays a key role in Histoplasma capsulatum pathogenesis (2007) (0)
Chromatographic purification of murine h-2 histocompatibility antigens. Abstr. (1976) (0)
Crystal Structure of the Immunoglobulin variable domain of Nectin-2 in monoclinic form (2013) (0)
Transplantation antigens. (1977) (0)
Dynamic equilibrium of B7-1 dimers and monomers is important for regulation of TCR/CD28 – mediated T cell activation (33.28) (2009) (0)
[75] UDP-N-acetylglucosamine: Polyribitol phosphate N-acetylglucosaminyltransferases from Staphylococcus aureus (1966) (0)
Crystal structure of the light and hvem complex (2015) (0)
From the Department of Tumor hnmunology , Central Laboratory of the Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical (0)
Crystal structure of the mouse PD-1 and PD-L2 complex (2008) (0)
Activated TCRs remain marked for internalization after dissociation from pMHC (2002) (0)
Crystal structure of the Class I MHC Molecule H-2Kwm7 with a Single Self Peptide IQQSIERL (2010) (0)
A novel approach to generate LIGHT mutants with selectivity to binding partners (TECH2P.925) (2015) (0)
Crystal structure of Pika GITRL (2012) (0)
Crystal structure of human TL1A extracellular domain C95S/C135S mutant (2008) (0)
Purification and properties of papain solubilized mouse h-2 isoanti- gens. Abstr. (1968) (0)
Specificity of interaction between MHC (major histocompatibility complex) class I molecules, antigenic peptides, and the T cell receptor (1991) (0)
Crystal structure of a single chain construct composed of MHC class I H-2Kd, beta-2microglobulin and a peptide which is an autoantigen for type 1 diabetes (2011) (0)
The PD-1/PD-L costimulatory pathway plays a key role in Histoplasma capsulatum pathogenesis (B122) (2007) (0)
Three distinct signals can induce class II gene expression in a murine pre-13-cell line ( B-ceil-stimulatory factor 1 / tmns-acting factor / gene regulation ) (0)
Crystal Structure of the Immunoglobulin variable domain of Nectin-2 (2011) (0)
CRYSTAL STRUCTURE OF THE CTLA-4/B7-2 COMPLEX (2001) (0)
Crystal structure of the complex between mouse PD-1 mutant and PD-L2 IgV domain (2011) (0)
Crystal structure of the D1 domain from human Nectin-4 extracellular fragment [PSI-NYSGRC-005624] (2013) (0)
Crystal structure of light mutant (2013) (0)
Crystal Structure of human GITRL variant (2007) (0)
TCR-Peptide / MHC Class I Interaction Profoundly Alter the Biological Outcome of Residue of the Antigenic Peptide Can A Structural Difference Limited to One and (2001) (0)
Crystal structure of the Ig-C2 type 1 domain from mouse Fibroblast growth factor receptor 2 (FGFR2) [NYSGRC-005912] (2012) (0)
Trinitrophenyl-Specific CTL Fine Specificity and MHC Restriction of Thomson (1999) (0)
CELL MEMBRANE ANTIGENS DETERMINED BY THE MOUSE MAJOR HISTOCOMPATIBILITY COMPLEX – SOME DATA AND SOME SPECULATIONS (1974) (0)
Crystal structure of human tl1a extracellular domain (2007) (0)
Exploration and blockade of the decoy strategy: crystal structure of the LIGHT:DcR3 complex and rational design of DcR3 antagonists (P1067) (2013) (0)
Selective inactivation of h-2 antigenic specificities by modification of amino acid side chain groups. Abstr. (1972) (0)
Crystal structure of the Ig-like D1 domain from mouse Carcinoembryogenic antigen-related cell adhesion molecule 15 (CEACAM15) [PSI-NYSGRC-005691] (2013) (0)
Nomenclature Revised nomenclature of mouse B-2 genes (1993) (0)
Crystal structure of the complex between the extracellular domains of mouse PD-1 mutant and human PD-L1 (2011) (0)
Vesicular stomatitis virus antigenic octapeptide N52-59 is anchored into the groove of the H-2Kb molecule by the side chains of three amino acids and the main-chain atoms of the amino terminus (major histocompatibility complex/major histocompatibility complex binding motif/T-cell receptor-peptide in (2016) (0)
Crystal structure of human B7-H4 IgV-like domain (2012) (0)
Genetic and structural strategies for MHC function. (1993) (0)
Evidence for the Existence of Separate Intact Macromolecules Carrying Different H-2 Antigen Sites1 (1971) (0)
Molecular Mapping of Antigenic and Cytotoxic T Lymphocyte Recognition Determinants on the Major Histocompatibility Complex Class I Molecule Kb Using In Vitro Mutant Cell Lines (1989) (0)
Biochemical properties of papain solubilized h-2d alloantigens from meth-a tumor cells. Abstr. (1970) (0)
Crystal Structure of mouse GITRL (2008) (0)
Primary structure of the mouse h-2kb alloantigen. Abstr. (1979) (0)
Structural and functional studies on PD-1: from crystals to mice (2011) (0)
Crystal structure analysis of Class-I MHC restricted T-cell associated molecule (2011) (0)
Nucleic acid sequences of the H-2Ksand H-2Ksm1genes (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Stanley G. Nathenson?

Stanley G. Nathenson is affiliated with the following schools:

Stanley G. Nathenson's Academic­Influence.com Rankings

Stanley G. Nathenson's Degrees

Why Is Stanley G. Nathenson Influential?

Stanley G. Nathenson's Published Works

Published Works

What Schools Are Affiliated With Stanley G. Nathenson?

Stanley G. Nathenson's AcademicInfluence.com Rankings